Filgrastim

Welcome to Dwaey, specifically on Filgrastim page.
This medicine contains important and useful components, as it consists of
Filgrastim is available in the market in concentration.

Generic Name of Filgrastim - Learn More

Filgrastim

Filgrastim Precaution - What You Need to Know

Before starting Filgrastim, it is critical that patients consult with their healthcare provider to ensure the medication is safe and appropriate for their condition. There are several important precautions to consider:

- Bone Marrow Disorders: Filgrastim stimulates the production of white blood cells, which can lead to complications in patients with certain bone marrow disorders. Patients with underlying bone marrow or blood cell abnormalities should be closely monitored.
- Splenomegaly: Filgrastim may cause splenomegaly (enlargement of the spleen), and it is crucial to monitor for signs of splenic rupture, which is a rare but serious side effect. Any unexplained left upper abdominal pain or shoulder tip pain should be reported immediately.
- Pregnancy and Lactation: Filgrastim falls under pregnancy category C. It should only be used during pregnancy if the potential benefits justify the risks to the fetus. It is excreted in breast milk, so breastfeeding mothers should use caution and consult their healthcare provider.
- Leukocytosis: Filgrastim increases the number of white blood cells, leading to leukocytosis (elevated white blood cell count). Monitoring the patient's white blood cell count is essential, as excessive white blood cell production can cause complications.
- Allergic Reactions: Though rare, patients may experience allergic reactions to Filgrastim, including rash, fever, dyspnea (difficulty breathing), and anaphylaxis. Any signs of an allergic reaction should be reported immediately.

Filgrastim Indication - Uses and Benefits

Filgrastim is primarily indicated for the treatment of conditions involving neutropenia (low white blood cell count), especially in patients undergoing chemotherapy or stem cell transplantation. Common indications include:

- Chemotherapy-Induced Neutropenia: Filgrastim is used to reduce the risk of infection by increasing the production of neutrophils (a type of white blood cell). This is particularly important for patients undergoing chemotherapy, as the treatment can significantly lower white blood cell counts, leaving them vulnerable to infections.
- Bone Marrow Disorders: Filgrastim is indicated for patients with certain bone marrow disorders, such as chronic neutropenia (persistent low white blood cell count), to help boost the production of neutrophils.
- Hematopoietic Stem Cell Mobilization: Filgrastim is used in stem cell mobilization protocols to increase the number of hematopoietic stem cells in the bloodstream, which can then be harvested for transplantation.
- Severe Chronic Neutropenia: Filgrastim is used in patients with congenital or idiopathic severe chronic neutropenia to prevent infections due to a persistent low neutrophil count.

Filgrastim Contraindications - Important Warnings

Filgrastim should be avoided in the following situations:

- Hypersensitivity: Filgrastim should not be used by individuals who have a known allergy to Filgrastim or any components of the formulation. Hypersensitivity reactions can range from mild to severe, including anaphylaxis.
- Sickle Cell Disease: Filgrastim is contraindicated in patients with sickle cell disease as it can exacerbate the disease by increasing the risk of sickle cell crises.
- Pregnancy (if benefits do not outweigh risks): Filgrastim is generally not recommended during pregnancy unless there are no suitable alternatives, as its safety in pregnancy has not been established.
- Breastfeeding (with caution): Filgrastim is excreted in breast milk and should be used cautiously in breastfeeding mothers, especially if no clear benefit outweighs the potential risks to the infant.

Filgrastim Side Effects - What to Expect

The most common side effects of Filgrastim include:

- Bone Pain: Bone pain is a frequent side effect of Filgrastim, as it stimulates the production of neutrophils in the bone marrow. This pain can be managed with analgesics.
- Fatigue: Some patients experience fatigue or weakness, which can affect daily activities.
- Fever and Chills: As the body responds to the medication, some patients may develop fever or chills.
- Rash: Filgrastim can cause skin rashes, which may be mild to moderate.
- Splenomegaly: Rarely, Filgrastim can cause splenomegaly (an enlarged spleen), which may lead to abdominal discomfort or pain.
- Injection Site Reactions: Local redness, swelling, or pain at the injection site are common, especially when administered subcutaneously.
- Increased White Blood Cell Count (Leukocytosis): While the goal of Filgrastim is to increase neutrophils, it can sometimes cause leukocytosis, a dangerously high white blood cell count. Monitoring blood counts is necessary during treatment.

Filgrastim Pregnancy Category ID - Safety Information

3

Filgrastim Mode of Action - How It Works

Filgrastim is a granulocyte colony-stimulating factor (G-CSF) that works by stimulating the bone marrow to produce neutrophils, a type of white blood cell that plays a key role in fighting bacterial infections. Filgrastim binds to the G-CSF receptor on hematopoietic progenitor cells, leading to their proliferation, differentiation, and the increased release of mature neutrophils into the bloodstream.

By increasing neutrophil production, Filgrastim enhances the body’s immune defense, particularly in patients with neutropenia (low neutrophil count), which can result from chemotherapy, bone marrow disorders, or stem cell transplantation. It helps reduce the risk of infections in these vulnerable patients by replenishing their neutrophil reserves.

Filgrastim Drug Interactions - What to Avoid

Several drug interactions can affect the safety and effectiveness of Filgrastim. Some key interactions include:

- Chemotherapy Drugs: Filgrastim can interact with chemotherapy drugs (e.g., alkylating agents or antimetabolites) that also target rapidly dividing cells. When used together, it may modify the efficacy of chemotherapy or cause additional side effects. Close monitoring of treatment efficacy and safety is necessary.
- Lithium: The use of lithium alongside Filgrastim may enhance the effects of granulocyte colony-stimulating factor (G-CSF). Caution is advised when combining these drugs, and the patient’s white blood cell count should be monitored frequently.
- Other Hematopoietic Growth Factors: Caution should be exercised when combining Filgrastim with other hematopoietic growth factors (e.g., GM-CSF). These interactions may alter the white blood cell count and lead to a risk of leukocytosis.
- Cyclosporine and Tacrolimus: The use of immunosuppressive drugs like cyclosporine and tacrolimus may alter the effectiveness of Filgrastim. Monitoring of blood counts and immune system function is important during concurrent use.

Filgrastim Adult Dose - Recommended Dosage

The typical dosing of Filgrastim depends on the condition being treated:

- For Chemotherapy-Induced Neutropenia: The standard dose is 5 mcg/kg/day administered subcutaneously, typically starting 24 hours after chemotherapy and continued until neutrophil recovery.
- For Severe Chronic Neutropenia: The recommended dose is 5 mcg/kg/day administered subcutaneously, with adjustments based on the patient’s response and white blood cell count.
- For Bone Marrow Transplantation: The dose is usually 10 mcg/kg/day, starting 24 hours after the stem cell infusion and continued until the absolute neutrophil count (ANC) reaches an acceptable level.

Filgrastim Child Dose - Dosage for Children

For pediatric patients, the typical dose of Filgrastim is 5 mcg/kg/day, administered subcutaneously, with dosing adjustments based on the child’s specific condition, response to treatment, and white blood cell count. Filgrastim is used in children with neutropenia, often as a preventative treatment during chemotherapy or to address severe chronic neutropenia.

It is essential to consult a healthcare provider to determine the appropriate dose based on the child’s condition and specific health needs.

Filgrastim Renal Dose - Dosage for Kidney Conditions

Filgrastim dosing may need to be adjusted in patients with renal impairment. Since Filgrastim is not significantly cleared through the kidneys, specific renal dose adjustments are usually not necessary. However, patients with severe renal dysfunction should be monitored closely for side effects such as splenomegaly or increased white blood cell counts.